Phenotypic evolution of cells resistant to bromodeoxyuridine

Insights

Bromodeoxyuridine (BrdUrd) resistance and thymidine kinase deficiency develop in V79 cells through a gradual, drug-induced transition. BrdUrd acts as both an inducer and selector, leading to complex cellular phenotypes over time.

Area of Science:

  • Cell biology
  • Genetics
  • Biochemistry

Background:

  • Bromodeoxyuridine (BrdUrd) is a thymidine analog used to study DNA synthesis and cell proliferation.
  • Thymidine kinase (TK) is a crucial enzyme in DNA precursor metabolism, phosphorylating thymidine and BrdUrd.
  • Drug resistance mechanisms in mammalian cells are complex and can involve multiple genetic and epigenetic alterations.

Purpose of the Study:

  • To investigate the mechanisms of bromodeoxyuridine (BrdUrd) resistance and thymidine kinase (TK) deficiency development in V79 Chinese hamster cells.
  • To characterize the phenotypic changes associated with prolonged BrdUrd exposure.
  • To explore the role of BrdUrd as both a selective and inductive agent in cellular evolution.

Main Methods:

  • Induction of drug resistance using spontaneous and drug-induced mutations in V79 cells.
  • Isolation of partially resistant clones via one-step selection in BrdUrd.
  • Long-term culture of tolerant populations in BrdUrd-containing medium.
  • Measurement of thymidine kinase activity and relative plating efficiency in hypoxanthine/aminopterin/thymidine (HAT) medium.
  • Clonal analysis to assess phenotypic modifications.

Main Results:

  • Prolonged BrdUrd exposure induced a gradual phenotypic transition, leading to complete BrdUrd resistance and thymidine kinase deficiency.
  • Thymidine kinase activity declined logarithmically over 8-10 weeks, correlating with increased growth rate.
  • Colony formation in HAT medium decreased exponentially for at least 18 weeks post-TK deficiency.
  • Phenotypic modifications were continuous or multistep, occurring in most cells maintained in BrdUrd.

Conclusions:

  • Bromodeoxyuridine (BrdUrd) can act as both an inductive and selective agent, driving the evolution of drug-resistant cell populations.
  • The development of BrdUrd resistance and thymidine kinase deficiency is a complex, multistep process.
  • New models are required to explain the progressive evolution of these cellular phenotypes.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Other Unique Bacteria01:18

Other Unique Bacteria

Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic and are commonly found near the...
Evolution of New Traits in Microbes01:24

Evolution of New Traits in Microbes

Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...